medtrad spring review quarter preview
last week attend medtrad spring meet second-largest home medic
equip hme trade show year overal came away meet
sens underli patient provid demand new technolog remain strong
bode well hme remain focus diversifi
busi offer new cash-pay product technolog improv
revenu cycl gener continu move toward nondeliveri model
despit tougher comp come quarter associ one larg provid
led us lower near-term estim believ full-year guidanc
achiev acceler growth expect throughout year long term continu
view market convers stori posit underli fundament poc
stock trade nearli year-to-d investor remain concern
domest comp busi trajectori said came away meet
encourag competit posit continu market move toward
nondeliveri model though pace market convert strategi
servic provid unknown ad recent stock volatil believ investor
sentiment larg factor uncertainti note stock trade
nearli half valuat peer group ev/sal basi less half
valuat peer group ev/ebitda basi time revenu target
million time ebitda target million
believ patient investor well reward market dynam settl
fundament come fore time rate stock outperform
continu believ manag place sever attract bet
factor upsid model although includ cost includ
smaller play potenti signific upsid larger one add scale
broader out-of-hospit copd strategi ultim believ core busi
quickli return strong growth rate compani continu improv product
portfolio help drive continu above-market growth exclud short-term
impact franc japan share trade time calendar ep estim
growth year-over-year rate stock outperform
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
market demand remain strong manufactur provid suggest grow demand poc demand come
larg nation describ purchas steadili smaller region similar somewhat odd
descript growth face near-term headwind one larg provid said encourag
consist commentari relat broad market trend toward nondeliveri poc model patient treat outsid
largest nation hme believ remain signific opportun continu strong growth comp eas
competit environ larg expect new product featur includ resm mobi
other de-emphasize overal feedback suggest poc remain product choic market
inogen devic featur meet though continu believ spec compel provid given
higher flow rate recal recent launch dtc channel expect launch provid next
sever month assum impact launch estim
despit posit commentari meet market adopt posit modestli lower estim
account larger-than-expect contribut one provid earli believ growth acceler
first-quart level estim first-quart sale million year-over-year million
previous full-year estim come million million previous low end
showcas sever new mask confer believ could drive share gain
top competitor support consum prefer data minim competit updat devic side
saa side launch new patient engag app advanc analyt latter add-on featur
provid new insight workflow revenu cycl manag resuppli program program also compar hme result
peer strong new launch help reacceler growth categori
believ continu launch number new evolutionari product come month
keep underli growth robust exclud impact franc japan though like take time prove
compani recent saa acquisit believ part larger play within respiratori broadli out-of-
near term expect headwind franc japan impact intern devic growth though believ
transient six- nine-month issu outsid franc japan expect see continu strong momentum sleep
busi model nearli america devic growth one easier comp year off-set modest intern
devic growth overal believ report revenu estim achiev estim fiscal third-quart adjust ep
line street estim inclus headwind relat verili jv
feedback confer suggest remain market leader poc categori hme demand poc remain
strong despit barrier convert busi model poc research confer suggest servic provid
increasingli move toward nondeliveri model believ market continu shift direct patient
driven diseas awar treatment option awar prefer poc
look first-quart full-year result proactiv lower sale estim given like larger-than-expect
headwind larg nation provid manag previous referenc expect headwind continu
mid-third quarter note new first-quart domest estim sale first quarter also assum
deceler growth segment sale exclud larg nation versu fourth quarter result
estim may prove conserv growth acceler cours year
decreas estim chang come spite bullish feedback confer suggest demand
poc remain robust stand benefit believ compani busi dtc intern could
also drive stronger-than-anticip growth throughout year view revis growth estim full year
low end guidanc achiev
posit commentari market growth hme adopt feedback confer suggest broad hme demand
poc remain strong manufactur indic continu see larg small provid convert busi
nondeliveri model sale driven primarili strong patient prefer poc particularli innov market
awar increas believ market remain attract convers stori poc penetr
today one fastest grow categori market
research suggest larg nation provid continu purchas poc steady-to-grow level acknowledg
commentari repres disconnect though compani see purchas larg nation recal
saw strong pickup order one larg nation first half signific growth first half
saw order slow second half year provid suffici restructur busi nondeliveri model
reportedli retir singl deliveri truck time frame provid continu purchas product though
lower level first half
believ primari beneficiari acceler purchas first half one larg
provid manufactur suggest us see similar materi uplift around time frame also
believ larg nation shift demand other mani much smaller would
impli potenti multipl manufactur revenu off-set excess demand instead believ larg nation
continu purchas varieti product typic suggest continu demand commit poc work
potenti strateg chang note inogen guidanc assum resolut provid come
exclud larg provid underli domest busi grew fourth quarter albeit smaller base
line research confer market demand poc remain strong remaind
marketplac serv roughli oxygen patient said updat model assum deceler growth
provid may prove conserv overal believ posit market commentari suggest provid larg small
continu convert poc model
competit environ appear stabl competit believ market rel stabl sens inogen
privat label product remain devic choic respiron second launch hme channel expect
come month augment compani market lead posit manufactur suggest hme cogniz
valu higher qualiti product will spend rel basi
respiron estim around market share launch new iter devic sinc
launch simplygo believ near-term product launch anticip compani may tri follow
market develop smaller lighter devic specif time frame announc
competitor present confer includ cair freestyl comfort poc launch august
display poc confer featur last year midst launch mobi precis
medic expect launch new poc summer target lower cost product view new surpris
competitor rel expect
lower near-term estim still confid full-year guidanc review model advanc first-
quarter result particularli regard difficult near-term domest comp estim one larg nation
larger impact first half result initi expect thu reduc full-year growth estim
channel regard full-year guidanc model growth full year lower end
manag rang believ prove achiev
decreas first-quart domest growth estim account larger scale one
larg nationalw estim mid- high singl digit percent compani revenu first half anticip
hme may tri fill gap gain share larg nation provid notabl saw underli growth
channel fourth quarter exclud larg provid albeit smaller base conserv model deceler
rang believ guidanc also assum deceler provid growth full year result
comfort new estim
modestli increas full-year estim dtc growth believ inogen new hire largest
bolu occur third quarter remain track toward reach full product goal second quarter
believ hire anoth expect increas net hire year modest improv season rep product
patient demand launch could collect drive dtc revenu growth beyond includ model
valuat discuss share come sinc start year trade time new revenu
target million growth believ reflect long-term potenti busi long term
continu view market convers stori posit underli fundament poc penetr still low rel
peer believ one attract name space level number level shown chart
convers confer attende suggest market growth demand remain robust across busi
sens price also remain rel stabl devic side compani showcas new mask
mobi poc saa side believ signific foot traffic compani showcas new advanc
analyt platform brightre believ compani well posit continu strong growth domest
saa solut busi help make prefer partner among hme payer environ view
sustain competit moat compani longer term
near term anticip headwind franc japan remain next sever quarter though believ strong
core growth busi geograph area make constant-curr growth estim quarter
constant-curr estim full fiscal year reason
innov sleep therapi help drive continu growth number new product display believ
compani continu run room iter exist product sustain continu growth margin improv
sleep busi
new product display includ launch januari launch last week mask intend round
portfolio address specif report patient provid pain point eas use reduc inventori need hme despit
respiron first market similar tube mask sens done well taken share believ
benefit still on-going similar opportun clinic studi patient found major
patient prefer respiron dreamwear gel pillow find seal better find easier
use expect market find drive share gain categori mask similar consum prefer
studi launch earlier year notabl design work cushion mask fewest sku
rel competitor go third quarter believ domest intern mask estim
respect achiev
term innov believ invest person therapi patient data driven
recent hardwar softwar improv launch given increas presenc partnership saa
expect compani launch product base data gather note compani also come five-
year mark myair platform though modest softwar enhanc time horizon latest
gener gener may area updat near midterm hardwar softwar
perspect would surpris compani design product gain data field patient
get today give advantag peer
hme demand saa solut remain strong brightre strong show confer view continu
innov allow opportun drive increas revenu per custom booth includ brightre
highlight advanc analyt platform patient hub patient engag app previous beta launch fall
confer advanc analyt expand brightre resuppli program includ modul revenu cycl manag
busi oper gener easy-to-us action data littl effort requir user believ attract
provid seek better effici tight reimburs environ user brightre platform use patient hub
app stay activ engag patient well
anticip compani continu build solut look way add valu custom
futur includ new web-port patient hub like launch summer growth brightre moder somewhat
recent quarter mid- high singl digit though expect pick come quarter return doubl digit
compani ramp new solut strategi consolid end-market recent launch
resuppli custom reason brightre believ help compani stay competit
saa roughli revenu today though compani expect increas larger percentag time near term
continu believ manag focu integr execut saa franchis market longer
term manag believ digit presenc help drive diagnosi sleep apnea copd patient broader scale
estim high-single-digit core brightre growth fiscal low doubl digit fiscal prove achiev
beatabl
competit landscap copd competit market remain stabl believ respiron showcas new
dreamwisp mask combin dreamwear wisp mask travel cpap humidif though believ
resm product remain competit respiron display orchestr saa platform platform
market three year modest improv
regard fisher paykel larg player mask space compani new mask display seem
experienc attende excit busi line high flow therapi
regard resm mobi poc full launch display continu believ devic help augment devic
revenu near term materi driver growth devic cloud connect yet sens compani
may add connect time abl leverag connected-car offer hme believ mobi competit
intend add valu copd channel time
believ concurr launch mobi llc establish fall manag paul william head
logist compani pilot program call oxyensur connect patient provid directli
on-line portal sens may offer oxyensur directli patient need program similar
model respiron compar inogen dtc sens oxyensur mobi devic devic
differ name program like test program help provid custom
